DSCSA Authorized Trading Partners: Roles, Verification, and Deadlines

Under the Drug Supply Chain Security Act, DSCSA authorized trading partners are the manufacturers, repackagers, wholesale distributors, dispensers, and third-party logistics providers that hold the specific federal registration or state license their role requires, and only these entities may legally buy, sell, or move prescription drugs in the U.S. supply chain.¹ If your counterparty is not authorized, you cannot transact with them. If you are not authorized, no one can transact with you. Since January 1, 2015, this has been a hard prohibition, not a best practice.²

The Five Types of Trading Partners

The DSCSA recognizes five categories of entities in the pharmaceutical distribution chain, and your authorization requirements depend on which one you are.³

Manufacturers hold an approved drug application or biologics license, or physically produce the drug. Co-licensed partners and affiliates receiving product directly from the application holder are treated the same way.
Repackagers take a finished drug and place it into a different container or relabel it for further distribution.
Wholesale distributors move drugs between businesses rather than to patients, linking manufacturers with pharmacies and hospitals.
Dispensers are retail pharmacies, hospital pharmacies, and chain pharmacies under common ownership that give prescription drugs to patients. Affiliated warehouses supplying those pharmacies count, provided they are not acting as wholesalers.
Third-party logistics providers (3PLs) warehouse, transport, or coordinate distribution on someone else’s behalf without ever taking ownership.

A trading partner, in the statutory sense, is any entity from which you accept ownership or possession of a drug, or to which you transfer it. The 3PL relationship is handled slightly differently because a 3PL transfers possession without ownership.³

What Authorization Actually Requires

Being a trading partner and being an authorized trading partner are two different things. The credentials that count are set out in 21 U.S.C. § 360eee(2).⁴

Manufacturers and Repackagers

Both must hold a valid FDA establishment registration under section 510 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 360). Registration renews annually during the October 1 to December 31 window, and every facility where drugs are made, repackaged, or relabeled needs its own registration.⁵ Let the registration lapse or have it revoked, and authorized status disappears the same day.

Wholesale Distributors

Wholesale distributors need a valid license from the state they distribute from. If that state has no wholesale distributor licensing program, the FDA issues the license instead. Distributors shipping interstate may also need a license in the receiving state where that state requires one.⁶ Annual licensure reporting to the federal government is also required.

Third-Party Logistics Providers

3PL licensing tracks the wholesale distributor structure: state license from the distributing state, or FDA license if the state does not license 3PLs, and a possible additional license in the destination state.⁷ Until the FDA finalizes its 3PL licensing regulations, a 3PL is considered licensed unless the agency has specifically found that the provider does not follow good handling and distribution practices.²

Dispensers

Pharmacies need a valid license under their own state’s law. There is no federal fallback license for dispensers the way there is for wholesalers and 3PLs. Suspend or revoke the state license, and the pharmacy is no longer an authorized trading partner. Upstream suppliers must stop shipping to it.

How to Verify a Partner Before You Transact

You cannot rely on a partner’s assurance that everything is in order. The prohibition on transacting with unauthorized entities applies whether or not you checked, so verification has to happen before the first shipment and continue on a schedule after that.

For manufacturers and repackagers, the FDA’s Drug Establishments Current Registration Site (DECRS) is a public database searchable by firm name or registration number. DECRS does not cover wholesale distributors or 3PLs.⁸

For wholesale distributors and 3PLs, the FDA recommends a two-step check: confirm the state license through the state licensing board’s website, then confirm the entity has filed its required annual report with the FDA through the agency’s reporting database.⁹ Cross-referencing catches the case where a state has revoked a license but the federal database has not caught up.

Dispenser verification runs through the relevant state pharmacy board.

During onboarding, ask for copies of every applicable license or registration confirmation and compare them against the government sources. Keep a timestamped record of each verification. Licenses lapse and get revoked mid-year, so periodic reverification is the only way to catch a partner whose status has changed since the last look.

The 2025 and 2026 Deadlines That Affect Authorization in Practice

The DSCSA’s long-term aim is an interoperable electronic system that traces individual prescription drug packages from manufacturer to patient.¹ The enhanced drug distribution security requirements officially took effect on November 27, 2023, and the FDA then issued staggered exemptions to give the industry time to build the systems.¹⁰

Manufacturers and repackagers: May 27, 2025
Wholesale distributors: August 27, 2025
Dispensers with 26 or more full-time employees: November 27, 2025
Small dispensers (25 or fewer full-time pharmacists and pharmacy technicians): November 27, 2026

When the exemption window closes for your category, your systems must support electronic, interoperable, package-level tracing. A company that cannot meet its deadline can request an individual waiver from the FDA, but filing the request does not pause the underlying obligation while the agency reviews it.¹⁰ Many organizations assume the request itself buys time. It does not.

When the Rules Bend

Small Dispensers

Pharmacies where the owning company had 25 or fewer full-time pharmacists and pharmacy technicians as of November 27, 2024 qualify as small dispensers and are exempt from the enhanced tracing requirements until November 27, 2026. Each pharmacy makes its own determination and no notification to the FDA is required. Trading partners transacting with a qualifying small dispenser can rely on the same exemption for those transactions.¹⁰ The authorized trading partner requirement itself still applies.

Public Health Emergencies

When the Secretary of Health and Human Services declares a public health emergency under section 319 of the Public Health Service Act, distribution to address that emergency is not a “transaction” under the DSCSA, so standard product tracing and wholesale distribution requirements do not apply to those emergency shipments. Every other DSCSA requirement, including the authorized trading partner mandate, still applies.¹¹ Declarations expire after 90 days unless renewed, and once the emergency ends, full requirements resume immediately with no grace period.

What Happens If You Transact With an Unauthorized Partner

If you find out a prospective partner lacks valid registration or licensing, you are legally required to refuse the transaction. There is no good-faith exception for skipping the check.²

The FDA can issue warning letters or seek court injunctions to stop operations. For knowing violations involving wholesale distribution of prescription drugs, individuals face up to 10 years in prison and fines up to $250,000.¹² Organizations convicted of a felony under these provisions can be fined up to $500,000 under the federal sentencing statute.¹³

The commercial fallout matches the legal exposure. Other trading partners will end relationships to protect their own compliance posture, and reputational harm in a supply chain built on traceability is slow to undo. If a partner’s license lapses or is revoked mid-relationship, the duty to stop transacting is immediate. You do not get a few weeks to wind down while you find another supplier.

1
U.S. Food and Drug Administration. Drug Supply Chain Security Act (DSCSA)
2
Office of the Law Revision Counsel. 21 U.S.C. 360eee-1 – Requirements
3
Office of the Law Revision Counsel. 21 U.S.C. 360eee – Definitions
4
GovInfo. 21 U.S.C. 360eee – Definitions
5
Office of the Law Revision Counsel. 21 U.S.C. 360 – Registration of Producers of Drugs or Devices
6
Office of the Law Revision Counsel. 21 U.S.C. 353 – Exemptions and Consideration for Certain Drugs
7
Office of the Law Revision Counsel. 21 U.S.C. 360eee-3 – National Standards for Third-Party Logistics Providers
8
U.S. Food and Drug Administration. Drug Establishments Current Registration Site (DECRS)
9
U.S. Food and Drug Administration. Check Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers
10
U.S. Food and Drug Administration. Waivers and Exemptions Beyond the Stabilization Period
11
U.S. Food and Drug Administration. Public Health Emergencies and DSCSA Requirements
12
Office of the Law Revision Counsel. 21 U.S.C. 333 – Penalties
13
Office of the Law Revision Counsel. 18 U.S.C. 3571 – Sentence of Fine